Trial to Evaluate an Optimization Procedure of Alveolar Recruitment During Transport Performed by Nurse Anesthetists in Intensive Care
ESCORTE
Randomized Controlled Trial to Evaluate an Optimization Procedure of Alveolar Recruitment During Transport Performed by Nurse Anesthetists in Intensive Care
1 other identifier
interventional
250
1 country
1
Brief Summary
Intra hospital transport of ICU patients is still at high risk of respiratory complications.We propose to determine if endotracheal tube clamping prior to disconnect ventilator allows to avoid oxygenation decrease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 6, 2019
CompletedFirst Posted
Study publicly available on registry
November 12, 2019
CompletedStudy Start
First participant enrolled
January 17, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 18, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 22, 2023
CompletedMay 31, 2024
May 1, 2024
3.9 years
November 6, 2019
May 30, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Measure of the pa02/Fi02
Evaluate the effectiveness of a procedure to avoid alveolar delisting, measured by the absence of a decrease in the PaO2/FiO2 ratio (before transport and 1 hour after return to bed) during an HIT performed by a nurse anaesthetist/caregiver team, of intubated and ventilated resuscitation patients in a controlled assisted volume.
1 hour after the end of the transport
Secondary Outcomes (6)
Assessment of the pa02
1 hour after the end of the HIT
Assessment of the pa02
immediately after the end of the HIT
Assessment of the pa02
6 hours after the end of of the HIT
length of stay
up to 28 days
duration of invasive ventilation
up to 28 days
- +1 more secondary outcomes
Study Arms (2)
Control group
NO INTERVENTIONThe transport will be released without a clamping of endotracheal tube before each disconnection from ventilator.
Clamping group
EXPERIMENTALThe transport will be released with a clamping of endotracheal tube before each disconnection from ventilator.
Interventions
The transport will be released in accordance with SFAR SRLF guideline. Before each disconnection from ventilator endotracheal tube will be clamped.
Eligibility Criteria
You may qualify if:
- intensive care patient
- intubated, sedated, controlled assisted ventilation
- Intra hospital transport for CT scan
- arterial catheter
- the patient or his trusted person consent to the study
You may not qualify if:
- Patient Covid tests positive or Covid test results not received
- extubated, unsedated,
- reinforced tube
- tracheotomy
- pregnancy
- guardianship
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Departement d'anesthésie et réanimation Gui de Chauliac (DAR C)
Montpellier, 34295, France
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 6, 2019
First Posted
November 12, 2019
Study Start
January 17, 2020
Primary Completion
December 18, 2023
Study Completion
December 22, 2023
Last Updated
May 31, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- CSR
- Time Frame
- 12 months after the main publication
- Access Criteria
- Data are provided to qualified investigators free of charge. Required documents to request data include a summary of the research plan, request form, and IRB review. Dataset will be shared after careful examination by the study board of investigators.